Location History:
- Taipei County, TW (2011)
- Shin-Dien, TW (2012)
- Taipei, TW (2019)
Company Filing History:
Years Active: 2011-2019
Title: Yi-Ling Lin: Innovator in Pharmaceutical Compounds
Introduction
Yi-Ling Lin is a prominent inventor based in Shin-Dien, Taiwan. He has made significant contributions to the field of pharmaceuticals, particularly in developing compounds that target specific protein kinases and glycosidases. With a total of 3 patents, his work has the potential to impact various medical treatments.
Latest Patents
One of Yi-Ling Lin's latest patents is focused on "Compounds to inhibit calcium/calmodulin dependent protein kinase II and applications thereof." This patent presents novel benzenesulfonamide compounds that inhibit calcium/calmodulin-dependent protein kinase II (CaMKII). The pharmaceutical compositions containing these compounds are designed to treat diseases associated with CaMKII activity, such as flavivirus infections.
Another significant patent is titled "Five-membered iminocyclitol derivatives as selective and potent glycosidase inhibitors: new structures for antivirals and osteoarthritis therapeutics." This patent describes novel 5-membered iminocyclitol derivatives that serve as potent and selective inhibitors of glycoprotein processing α- and β-glucosidase. These compounds have shown activity against various viruses, including the Japanese encephalitis virus and dengue virus serotype 2, as well as potential applications in osteoarthritis therapeutics.
Career Highlights
Yi-Ling Lin is affiliated with Academia Sinica, a prestigious research institution in Taiwan. His work has garnered attention for its innovative approach to addressing complex medical challenges. His research has contributed to the understanding of protein kinases and glycosidases, paving the way for new therapeutic strategies.
Collaborations
Throughout his career, Yi-Ling Lin has collaborated with notable colleagues, including Pi-Hui Liang and Chi-Huey Wong. These collaborations have enhanced the scope and impact of his research, leading to advancements in pharmaceutical development.
Conclusion
Yi-Ling Lin is a distinguished inventor whose work in pharmaceutical compounds has the potential to revolutionize treatments for various diseases. His innovative patents reflect a commitment to advancing medical science and improving patient outcomes.